Medical Patent News

RSS

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Conceptus obtains Ovion intellectual property rights from American Medical Systems

Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.

6 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

PrimeraDx receives its fourth patent

PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has received its fourth patent. The patent, entitled “Methods and systems for dynamic gene expression profiling”, with inventor Vladimir Slepnev, Ph.D., describes a novel method of quantitative analysis of gene expression allowing simultaneous interrogation of multiple genes in a single tube reaction.

5 Oct 2009

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement

Caraco Pharmaceutical Laboratories, Ltd. announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA") transaction with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business.

3 Oct 2009

RXi receives USPTO notices of allowance for certain siRNA sequence-specific patent applications

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).

From Thermo Fisher Scientific Inc. 3 Oct 2009

USPTO grants Micardia's patent concerning reshaping the anatomy of the heart

MiCardia® today announced that The United States Patent Office granted patent number US7,594,887 B2, "Shape Memory Devices and Methods for Reshaping Heart Anatomy," on September 29th, 2009.

3 Oct 2009

SIS files a patent aplication for a method of generating structured light for 3D image rendering

Spatial Integrated Systems, Inc. ("SIS"), a leader in the development and integration of solutions incorporating next-generation digital 3D data capture and processing technologies, announced today that a United States patent application has been published for "system and method for generating structured light for 3-dimensional image rendering" under Publication No. US2009/0169095A1.

3 Oct 2009

China's State Intellectual Property Bureau grants patent for Aoxing Ganbao

Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has received a patent from China's State Intellectual Property Bureau for its Aoxing Ganbao product. The patent number is 551073.

2 Oct 2009

USPTO allows BioMarin's claims covering the approved administration of sapropterin dihydrochloride with food

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.

1 Oct 2009

TSO3 files patent application for innovations made to its sterilization systems

TSO3 Inc., an innovator in low temperature sterilization technology for medical devices in healthcare settings, through the use of ozone (a cost effective, safe and eco-friendly method) today announced that it has filed a patent application in the United States seeking protection in that market as well as preserving rights in many other countries of recent innovations made to its sterilization systems, which enable both significantly faster and gentler cycles.

1 Oct 2009

Altered state physiology drug development platform to treat an array of human conditions

David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.

1 Oct 2009

Boston Scientific, Johnson & Johnson resolve patent disputes through settlement

Boston Scientific Corporation today announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the Palmaz-NIR suit. All the disputes involved intellectual property in the interventional cardiology arena. In connection with the settlement, Boston Scientific will make a payment of $716 million to Johnson & Johnson. The settlement payment is within Boston Scientific's existing reserve for the Palmaz-NIR suit and will be made from existing cash on hand.

1 Oct 2009

U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

Idaho Technology’s patent portfolio continues to grow as the U.S. Patent and Trademark Office granted the company U.S. Patent No. 7,582,429 relating to methods of performing genetic analysis in the presence of a double-stranded nucleic acid binding dye.

30 Sep 2009

Nutraceutix receives Chinese patent for probiotic and nutraceutical delivery technology

The Chinese Patent Office has issued Nutraceutix, Inc. patent No. 02823678.5 for BIO-tract. It is the fourth international patent, from many patents pending, that the technology has been awarded recently based on BIO-tract's ability to protect sensitive ingredients such as probiotic organisms from stomach acid on their way to optimal release sites in the intestinal tract.

30 Sep 2009

Cordis Corporation, Boston Scientific enter agreement to resolve Palmaz infringement suit

Cordis Corporation (“Cordis”) announced today that it has reached an agreement with Boston Scientific (“Boston”) resolving its Palmaz infringement suit relating to Boston’s NIR stent, settling several other cardiology-related cases relating to patents in the Ding, Kastenhofer, Palmaz, and Fontirroche patent families, and exchanging paid-up licenses for certain intellectual properties.

30 Sep 2009

IP Advocate founder to speak on commercialization barriers faced by university faculty inventors

Speaking of the then-divided Berlin, former President Reagan famously admonished Soviet leader Gorbachev to “tear down this wall.” In a similar spirit, IP Advocate founder Dr. Renee Kaswan is calling on the university technology transfer system to remove the barriers that keep innovations from moving swiftly into the marketplace.

29 Sep 2009

U.S. PTO to reexamine the patents in Cellectis-Precision BioSciences litigation

Precision BioSciences, Inc. today announced that the United States Patent and Trademark Office (PTO) has granted Precision’s requests for inter partes reexamination of U.S. Patent Nos. 6,610,545 (the ‘545 patent) and 7,309,605 (the ‘605 patent), which Cellectis SA (Alternext: ALCLS) has asserted against Precision in litigation.

29 Sep 2009

PolyMedix receives patent protection for computational methods in the design of amphiphilic polymers

PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, “Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers.”

28 Sep 2009

Illumina to defend Genome Analyzer System patent infringement suit

Illumina, Inc. today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents.

From Illumina, Inc. 28 Sep 2009

Medical Patent News

Vivaldi receives US patent for live attenuated influenza vaccines

Conceptus obtains Ovion intellectual property rights from American Medical Systems

MSF calls on drug companies to pool HIV patents

PrimeraDx receives its fourth patent

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement

RXi receives USPTO notices of allowance for certain siRNA sequence-specific patent applications

USPTO grants Micardia's patent concerning reshaping the anatomy of the heart

SIS files a patent aplication for a method of generating structured light for 3D image rendering

China's State Intellectual Property Bureau grants patent for Aoxing Ganbao

USPTO allows BioMarin's claims covering the approved administration of sapropterin dihydrochloride with food

TSO3 files patent application for innovations made to its sterilization systems

Altered state physiology drug development platform to treat an array of human conditions

Boston Scientific, Johnson & Johnson resolve patent disputes through settlement

U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

Nutraceutix receives Chinese patent for probiotic and nutraceutical delivery technology

Cordis Corporation, Boston Scientific enter agreement to resolve Palmaz infringement suit

IP Advocate founder to speak on commercialization barriers faced by university faculty inventors

U.S. PTO to reexamine the patents in Cellectis-Precision BioSciences litigation

PolyMedix receives patent protection for computational methods in the design of amphiphilic polymers

Illumina to defend Genome Analyzer System patent infringement suit

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News